The leukotrienes (LTs) (1) constitute a family of arachidonic acid metabolites involved not only in inflammatory or pathological processes but also in neuroendocrine functions. Formation of LTs is initiated by the 5-lipoxygenation of arachidonic acid to yieid (5S)-5-hydroperoxy-6-trans-8,11,14-cisicosatetraenoic acid (5-HPETE).
Lipoxygenase catalysis involves stereospecific abstraction of hydrogen, and in this case the D-hydrogen at C-7 of arachidonic acid is preferentially removed (2) . In the following conversion (5S)-5-trans-5,6-oxido-7,9-trans-11,14-cis-icosatetraenoic acid (LTA4)] the D-hydrogen at C-10 is also removed (3, 4) . Thus, there are mechanistic similarities between these two reactions, and recently we demonstrated that a single enzyme (from potato tubers) catalyzed both reactions by virtue of its dual lipoxygenase activities (5-lipoxygenase and 8-lipoxygenase) (5) . In this paper we present data showing that also a single enzyme from a mastocytoma cell line converts arachidonic acid to (4) . Arachidonic acid and 8,11,14-cisicosatrienoic acid (C20:3) were from Nu Chek Prep; linoleic acid was from Sigma. 5-HPETE,' [1-14C] 5-HPETE, and [10D-3H;3-14C]5-HPETE were prepared by using potato lipoxygenase (5). 13-Hydroxylinoleic acid was synthesized by using soybean lipoxygenase (Sigma). AA-861 [2,3,5- trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1 ,4-benzoquinone] (6) was kindly provided by Takeda Pharmaceutical (Osaka, Japan); 5,6-methano-LTA4 (7) , (5S,12R)-5,12-dihydroxy-6,14-cis-8,10-trans-icosatetraenoic acid (LTB4), and prostaglandin B2 (PGB2) were from Ono Phgrmaceutical (Osaka, Japan). The FPLC system equipped with columns Mono Q (HR 5/5) and Superose TM 12 (HR 10/30) was a product of Pharmacia. A hydroxyapatite column (Bio-Gel HPHT 0.78 x 10 cm, Bio-Rad) was used in connection with the FPLC system.
Assay of LTA4 Synthase. HPLC method. The standard assay mixture contained 0.1 M Tris HCl buffer (pH 7.5), 2 mM CaCl2, 2 mM ATP, the microsomal protein from PB-3c cells (1 mg/ml), and enzyme in a total volume of 0.5 ml. The microsomal fraction, an activator of 5-lipoxygenase (8) , also stimulated the LTA4 synthase reaction by 10-30%. After preincubation (30°C, 2 min) the incubation (5 min) was initiated by addition of 5-HPETE (50 ,uM, 25 nmol in 3 ,l of ethanol). The reaction was terminated by addition of 1 ml of methanol (-20°C) with 800 pmol of PGB2 as internal standard. Following centrifugation, the supernatant was evaporated to dryness and reconstituted in 0,1 ml of solvent A [acetonitrile/methanol/H20/acetic acid, 3:1:3:0.006 (vol/ vol), containing 0.05% EDTA]. HPLC anialysis was performed with a TSK gel ODS column 80-TM (4.6 x 150 mm, Toyo Soda) eluted with solvent A (1 ml/min), and the absorbance at 270 nm was monitored. Enzyme activity was estimated from the ratio of peak areas (LTA4-derived products to PGB2). When C20:3 was included in the reaction mixture as an inhibitor, [1-14C]5-HPETE (25 nmol, 86,000 cpm) was used as a substrate, and the radioactivity corresponding to hydrolysis products of LTA4 was measured. The recoveries of LTs and PGB2 were constant (95-97%).
Spectrophotometric methods. The incubation mixture was as described above except that. ATP was omitted. After addition of 5-HPETE, the increase in the absorbance at 275 nm was followed. This method was less appropriate, since the omission of ATP diminished the activity by 30-50%. Assay with methanol/H20/acetic acid, 75:25:0.01 (vol/vol) (1 ml/ min), and the absorbance at 234 nm was monitored. Lipoxygenase activity was determined from the ratio of peak areas [(5S)-5-hydroxy-6-trans-8,11,14-cis-icosatetraenoic acid (+ 5-HPETE) to the internal standard; recoveries >88%]. C20:3 8-lipoxygenase activity was measured essentially as described above, except that arachidonic acid was replaced by C20:3. In all assays, 1 unit of activity was defined as that producing 1 nmol of product per 5 min at 30°C.
Cells. The interleukin-3 (IL-3)-producing murine WEHI-3b cell line (9) Homogenates of PB-3c cells (5 x 108 cells in buffer A, 10 ml) were subjected to centrifugation as indicated. The pellet was resuspended in 1 ml of buffer A.
Clinical Immunology, University of Bern, Switzerland. The mouse bone marrow-derived mast cell line (PB-3c) (10) was generously provided by J.-F. Conscience of Friedrich Miescher Institute, Basel, Switzerland, and was further subcloned for more satisfactory IL-3-dependent proliferation. WEHI-3b-conditioned medium was prepared as described (9) . The subclone of PB-3c was maintained by regular passages in 50 vol of fresh RPMI-1640 medium supplemented with 10% fetal bovine serum, 0.05 mM 2-mercaptoethanol, and 10% WEHI-3b-conditioned medium at intervals of 3-4 days. Cells at confluence were harvested and used as the enzyme source. After washing, cells (2.5 x 109) were suspended in 50 ml of 20 mM potassium phosphate buffer, pH 7.4/0.1 M NaCl/2 mM EDTA/0.5 mM dithiothreitol (buffer A) saturated with N2 gas.
Purification of LTA4 Synthase from PB-3c Cells. All procedures were carried out at 0-40C, except for FPLC chromatographies (room temperature). Buffers were saturated with N2 gas and degassed thoroughly before use. Protein concentrations were determined according to Bradford (11) with bovine serum albumin as standard. The cell suspension was homogenized by sonication (Branson B-12, output 4, 5 X 10 sec). After centrifugation (10,000 x g, 15 min) the supernatant (referred to as crude extracts) was subjected to ammonium sulfate fractionation. The precipitate between 35% and 60% was reconstituted in 7.5 ml of 20 mM Tris HCl, pH 8/1 mM EDTA/0.5 mM dithiothreitol/20% glycerol (buffer B) and applied to three PD-10 columns (Pharmacia) equilibrated with the same buffer. The pooled macromolecule fractions (10.5 ml) were concentrated to 3 ml (ultrafiltration, PM 10,  Amicon). After filtration (Millipore, 0.22 tkm) the sample (3 x 1 ml) was applied to the Mono Q column equilibrated with buffer B. The enzyme was eluted by increasing the ionic strength as shown in Fig. 1A . Active fractions were combined and concentrated, and the buffer was changed (PD-10) to 5 mM potassium phosphate buffer, pH 7.6/1 mM EDTA/1 mM dithiothreitol/20% glycerol (buffer C).
This sample was applied to the hydroxyapatite column equilibrated with buffer C. The enzyme was eluted by increasing the concentration of potassium phosphate (up to 0.3 M) at a flow rate of 0.4 ml/min. The pool of active fractions was concentrated to 0.4 ml by using a Centricon 10 (Amicon). tYield was calculated on the basis of the LTA4 synthase activity. The final purification step was gel filtration on Superose TM 12 eluted with 20 mM potassium phosphate buffer, pH 7.4/0.2 M NaCl/1 mM EDTA/0.5 mM dithiothreitol/20% glycerol (buffer D, 0.3 ml/min). Active fractions as indicated by the arrows were combined and are referred to as the purified enzyme (Fig. 1B) .
RESULTS
Enzymatic Synthesis of LTA4. When 5-HPETE was incubated with crude extracts of cell homogenates, as shown in Fig. 2A, 6 -trans-LTB4, 12-epi-6-trans-LTB4, LTB4, and (5S,12S)-5,12-dihydroxy-6,10-trans-8,14-cis-icosatetraenoic acid (5,12-DiHETE) were formed. Ca2' and ATP were required for the synthesis of the former three compounds (peaks 2-4), whereas the formation of 5,12-DiHETE was only slightly affected (Fig. 2B) . When the purified enzyme was used instead of crude extracts, only the isomers of 6-trans-LTB4 were observed. These results indicate that the cell homogenates contained LTA4 synthase, LTA4 hydrolase, and 12-lipoxygenase; the latter two enzymes were removed during purification. The existence of an epoxide intermediate (LTA4) was demonstrated as follows. First, 1-min incubations of 5-HPETE (25 nmol) with enzyme (0.1 mg of protein, 180 units/mg) were terminated by addition of 10 vol of acidic methanol (12) . The products were extracted with diethyl ether and subjected to reverse-phase HPLC in solvent A. A pair of peaks (18.2 and 19.8 min) showed UV spectra with maxima at 258, 269, and 280 nm. The compounds were converted to methyl ester trimethylsilyl ether derivatives and analyzed by GC/MS. Both Table 1 ). The purification procedure gave a protein of about 85% purity, as judged by NaDod-S04/PAGE, and the yield was 0.6%. LTA4 synthase and 5-lipoxygenase copurified, and the ratio of the two activities was 0.08-0.1 after Mono Q column chromatography ( Table  2 ). The diverging ratio in the crude preparations may reflect nonenzymatic formation of LTA4 (13) . A major band (Mr 75,000) always appeared on the NaDodSO4 gel in parallel with the enzyme activity, whereas the Mr was estimated to be 50,000-55,000 by gel filtration (Superose TM 12). The enzyme was unstable especially after Mono Q column chromatography, even in the presence of glycerol, dithiothreitol, and EDTA, and under anaerobic conditions, which all partially stabilized the enzyme. Addition of microsomal protein from the PB-3c cells back to the purified enzyme (or to the 105,000 x g supernatant of the homogenate, Table 1 ) stimulated enzyme activities, as shown for 5-lipoxygenase from human leukocytes. In contrast, there was no similar stimulatory effect of the protein nonadsorbing to the Mono Q column (8, 14) .
Synthesis of LTA4 proceeded almost linearly for the first 2-3 min (Fig. 3A) , was dependent of the amount of enzyme (up to 10 Ag), and was diminished by boiling for 3 min (Fig.   3B ). The enzyme required Ca2l for full activity; the halfeffective dose was -0.1 mM (Fig. 3C) . Omission of ATP from the reaction mixture decreased the activity by almost 50%. When cells were treated with 2 ,uM Ca ionophore (A23187, Calbiochem) for 5 min in Tyrode solution and washed with buffer A prior to homogenization, the enzyme activity of the 5 3C Biochemistry: Shimizu et al. 10 ,000 x g supernatant was lowered by 25-30% compared to the control. The inclusion of EDTA during all steps of the enzyme purification was in fact required for obtaining reproducible enzyme activities. When the purified enzyme (2.4 ,ug) was incubated with 80
,M arachidonic acid (with Ca2' and ATP), about 7.4 nmol of 5-HPETE and 2.1 nmol of LTA4 were produced. The enzyme produced about 2.5 times more LTA4 when incubated with arachidonic acid than with 5-HPETE (50 ,uM), although less 5-HPETE was formed in the arachidonate incubation. Also under standard assay conditions, the purified enzyme (2.4 ,g) acted on C20:3 to give 0.8 nmol of 8-hydroperoxy-9,11,14-icosatrienoic acid (identified by HPLC, UV spectroscopy, and GC/MS; data not shown).
Heat Inactivation and Inhibitors. When the enzyme was treated for 3 min at various temperatures, 5-lipoxygenase and LTA4 synthase activities decreased concomitantly (Fig. 4) . In the crude extracts, however, about 25% of the LTA4 synthase activity was heat-resistant (13) . The lipoxygenase inhibitors AA-861 (Fig. 4) 12) and indicated that the enzyme(s) involved were cytosolic (15) . Here, we describe a cytosolic, Ca2+-requiring LTA4 synthase from murine mast cells. The PB-3c cell line was chosen because of the prominent conversion of arachidonic acid by the 5-lipoxygenase pathway. In our hands, the specific activity of LTA4 synthase in these cells was about 6 times higher than in RBL cells and 2.5 times higher than in human leukocytes (data to be published elsewhere).
The LTA4 synthase from PB-3c cells was purified to about 85% homogeneity. Many properties were similar to those of mammalian arachidonate 5-lipoxygenases (8, (14) (15) (16) (17) (18) (19) : the molecular weight (75,000), the acidic isoelectric point, and the requirements for Ca2+ and ATP. In addition, there are mechanistic similarities between the reactions catalyzed by 5-lipoxygenase and LTA4 synthase (5). Thus, several criteria suggested the identity of LTA4 synthase with arachidonate 5-lipoxygenase. This concept was further supported by the following findings: (i) both enzyme activities copurified (Table 2 ) and coeluted in three principally different FPLC chromatographies; (it) both enzyme activities responded practically identically to heat treatment and to inhibitory agents (Fig. 4) ; (iii) C20:3 was a substrate for the enzyme (oxygenated at C-8), which inhibited LTA4 synthase and 5-lipoxygenase activities; (iv) when the purified enzyme was incubated with [1OD-3H:3-14C]5-HPETE, a selective elimination of the lOD-hydrogen was observed, in agreement with data on the mechanism of LTA4 synthesis in intact cells (3, 4) .
The data presented here indicate that in murine mast cells, as was demonstrated recently for LTA4 formation in human leukocytes (20) , a single enzyme catalyzes 5-lipoxygenation and further conversion to LTA4. These findings are of considerable interest in connection with physiologic and therapeutic control of LT formation.
